Persistent endothelial dysfunction after glycaemic improvement: intervention timing and functional outcomes

Endothelial dysfunction can persist after glycaemic improvement, but the evidence for its reversal depends on when treatment starts and which outcome is measured. This targeted narrative review compares experimental glucose-withdrawal studies, human vascular investigations and clinical follow-up reports by exposure, intervention timing, cellular source and endpoint. Persistent abnormalities involve inflammatory chromatin regulation, redox signalling, mitochondrial maintenance, DNA methylation and endothelial repair. Interventions started during glucose lowering improved arterial relaxation or reduced microvascular leakage in experimental models. Mitochondrial interventions improved organelle measurements without establishing vascular functional recovery. Evidence for treatment after a documented period of persistence is limited: selected studies measured repair behaviour, inflammatory responses or organ function, with unresolved timing or pretreatment-state limitations. These findings do not establish sustained reversal of an established endothelial deficit. Human studies report improvement in selected forearm and skin responses and acute glucagon-like peptide-1 responsiveness, alongside studies with no detectable improvement in flow-mediated dilation. A qualitative examination that sets aside reports with uncertain schedules or incomplete assessment retains support for endpoint-specific modifiability during glucose lowering; the evidence for delayed reversal remains limited. Endocrine, mitochondrial and vascular observations from separate settings do not establish a complete causal pathway. Sex representation and donor replication further constrain generalisation. Recovery studies should document the pretreatment deficit under stable, improved glycaemia, pair molecular and vascular measurements, and assess benefit during continued treatment and after withdrawal. Effects on clinical events require separate evaluation.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-16
DOI
https://doi.org/10.3389/fendo.2026.2030665
Primary Topic
Nitric Oxide and Endothelin Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Persistent endothelial dysfunction after glycaemic improvement: intervention timing and functional outcomes

Yihong Wei, X Y Feng, Si-Yu Qiao, Lin Shen et al.
2 links
Frontiers in Endocrinology
Nitric Oxide and Endothelin Effects
article

Persistent endothelial dysfunction after glycaemic improvement: intervention timing and functional outcomes

Yihong Wei, X Y Feng, Si-Yu Qiao, Lin Shen, Duan Zhou, Yuan-ye Gu, Yan-yun Ma
article en

Abstract

Endothelial dysfunction can persist after glycaemic improvement, but the evidence for its reversal depends on when treatment starts and which outcome is measured. This targeted narrative review compares experimental glucose-withdrawal studies, human vascular investigations and clinical follow-up reports by exposure, intervention timing, cellular source and endpoint. Persistent abnormalities involve inflammatory chromatin regulation, redox signalling, mitochondrial maintenance, DNA methylation and endothelial repair. Interventions started during glucose lowering improved arterial relaxation or reduced microvascular leakage in experimental models. Mitochondrial interventions improved organelle measurements without establishing vascular functional recovery. Evidence for treatment after a documented period of persistence is limited: selected studies measured repair behaviour, inflammatory responses or organ function, with unresolved timing or pretreatment-state limitations. These findings do not establish sustained reversal of an established endothelial deficit. Human studies report improvement in selected forearm and skin responses and acute glucagon-like peptide-1 responsiveness, alongside studies with no detectable improvement in flow-mediated dilation. A qualitative examination that sets aside reports with uncertain schedules or incomplete assessment retains support for endpoint-specific modifiability during glucose lowering; the evidence for delayed reversal remains limited. Endocrine, mitochondrial and vascular observations from separate settings do not establish a complete causal pathway. Sex representation and donor replication further constrain generalisation. Recovery studies should document the pretreatment deficit under stable, improved glycaemia, pair molecular and vascular measurements, and assess benefit during continued treatment and after withdrawal. Effects on clinical events require separate evaluation.

Frontiers in EndocrinologyVol. 17
Shanghai University of Traditional Chinese Medicine (CN), Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
Shanghai Municipal Health Commission, National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Nitric Oxide and Endothelin Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon